Serum amyloid A is a chemotactic agonist at FPR2, a low-affinity N-formylpeptide receptor on mouse neutrophils

Biochemical and Biophysical Research Communications

Volumn 270, Issue 2, 2000, Pages 331-335

  Liang, Thomas S ^a   Wang, Ji Ming ^b   Murphy, Philip M ^a   Gao, Ji Liang ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemoattractant; G protein coupled receptor; Inflammation; Neutrophil; Serum amyloid A

Indexed keywords

FORMYLPEPTIDE; FORMYLPEPTIDE RECEPTOR; G PROTEIN COUPLED RECEPTOR; SERUM AMYLOID A; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CHEMOTAXIS; DOSE RESPONSE; GENETIC TRANSFECTION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALIA;

EID: 0034643268     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2416     Document Type: Article

References (22)

1. Jensen L., Whitehead A. S. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 334:1998;489-503.
2. Steel D. M., Whitehead A. S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyoid A protein. Immunol. Today. 15:1994;81.
3. Sipe J. D. The acute-phase response. Oppenheim J. J., Shevach E. M. Immunophysiology: The Role of Cells and Cytokines in Immunity and Inflammation. 1990;359-373 Oxford University Press, New York.
4. Liang J. S., Sipe J. D. Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux. J. Lipid Res. 36:1995;37-46.
5. Kisilevsky R. Serum Amyloid A (SAA), a protein without a function: Some suggestions with reference to cholesterol metabolism. Medical Hypotheses. 35:1991;337-341.
6. Meek R. L., Urieli-Shoval S., Benditt E. P. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: Implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA. 91:1994;3186-3190.
7. Stone M. J. Amyloidosis: A final pathway for protein deposition in tissues. Blood. 75:1990;531.
8. Husebekk A., Skogen B., Husby G., Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils. Scand. J. Immunol. 21:1985;283-287.
9. Benson M. D., Cohen A. S. Serum amyloid A protein in amyloidosis, rheumatic and neoplastic diseases. Arthritis Rheum. 22:1979;36-46.
10. Shirahama T., Mirua K., Ju S. T., Kisilevsky R., Gruys E., Cohen A. S. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab. Invest. 62:1990;61-68.
11. Fuks A., Zucker-Franklin D. Impaired Kupffer cell function precedes development of secondary amyloidosis. J. Exp. Med. 161:1985;1013-1028.
12. Badolato R., Wang J. M., Murphy W. J., Lloyd A. R., Michiel D. F., Bausserman L. L., Kelvin D. J., Oppenheim J. J. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180:1994;203-209.
13. Su S. B., Gong W., Gao J.-L., Shen W., Murphy P. M., Oppenheim J. J., Wang J.-M. A seven-transmembrane, G protein-coupled receptor, FPRL1R, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:1999;395-402.
14. Durstin M., Gao J.-L., Tiffany H. L., McDermott D., Murphy P. M. Differential expression of the members of the N-formylpeptide receptor gene cluster in human phagocytes. Biochem. Biophys. Res. Commun. 201:1994;174-179.
15. Su S. B., Gao J.-L., Gong W., Dunlop N. M., Murphy P. M., Oppenheim J. J., Wang J. M. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors. J. Immunol. 162:1999;5924-5930.
16. Fiore S., Maddox J. F., Perez H. D., Serhan C. N. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 180:1994;253-260.
17. Ye R. D., Cavanagh S. L., Quehenberger O., Prossnitz E. R., Cochrane C. G. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem. Biophys. Res. Commun. 184:1992;582-589.
18. Bao L., Gerard N. P., Eddy R. L. Jr., Shows T. B., Gerard C. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics. 13:1992;437-440.
19. Gao J.-L., Chen H., Filie J. D., Kozak C. A., Murphy P. M. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics. 51:1998;270-276.
20. Takano T., Fiore S., Maddox J. F., Brady H. R., Petasis N. A., Serhan C. N. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors. J. Exp. Med. 185:1997;1693-1704.
21. Hartt J. K., Barish G., Murphy P. M., Gao J.-L. N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR. J. Exp. Med. 190:1999;741-747.
22. Gao J.-L., Lee E. J., Murphy P. M. Impaired anti-bacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 189:1993;657-662.